DE2308362A1 - Psychopharmakologisch aktive peptide und peptidderivate - Google Patents

Psychopharmakologisch aktive peptide und peptidderivate

Info

Publication number
DE2308362A1
DE2308362A1 DE19732308362 DE2308362A DE2308362A1 DE 2308362 A1 DE2308362 A1 DE 2308362A1 DE 19732308362 DE19732308362 DE 19732308362 DE 2308362 A DE2308362 A DE 2308362A DE 2308362 A1 DE2308362 A1 DE 2308362A1
Authority
DE
Germany
Prior art keywords
met
group
phe
glu
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19732308362
Other languages
German (de)
English (en)
Inventor
Hendrik Marie Greven
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of DE2308362A1 publication Critical patent/DE2308362A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE19732308362 1972-02-22 1973-02-20 Psychopharmakologisch aktive peptide und peptidderivate Pending DE2308362A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7202278A NL7202278A (enExample) 1972-02-22 1972-02-22

Publications (1)

Publication Number Publication Date
DE2308362A1 true DE2308362A1 (de) 1973-09-06

Family

ID=19815436

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19732308362 Pending DE2308362A1 (de) 1972-02-22 1973-02-20 Psychopharmakologisch aktive peptide und peptidderivate

Country Status (12)

Country Link
US (1) US3853836A (enExample)
JP (1) JPS4896586A (enExample)
AU (1) AU471298B2 (enExample)
BE (1) BE795788A (enExample)
CA (1) CA1030953A (enExample)
CH (1) CH585192A5 (enExample)
DE (1) DE2308362A1 (enExample)
FR (1) FR2181759B1 (enExample)
GB (1) GB1416271A (enExample)
HU (1) HU168890B (enExample)
NL (1) NL7202278A (enExample)
ZA (1) ZA73839B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7607684A (nl) * 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
US4623715A (en) * 1984-10-22 1986-11-18 Hoechst Aktiengeselleschaft Novel peptides which are active on the central nervous system and have an action on the cholinergic system
NZ214543A (en) * 1984-12-14 1990-03-27 Australian Commercial Research Amino acid and peptide derivatives that inhibit human leucocytic elastase enzyme (hle)
US5462927A (en) * 1985-04-30 1995-10-31 The Administrators Of The Tulane Educational Fund Peptides aiding nerve regeneration
JP2525798B2 (ja) * 1987-03-12 1996-08-21 第一製薬株式会社 ペプチド誘導体
WO1993000922A1 (en) * 1991-07-01 1993-01-21 The Administrators Of The Tulane Educational Fund Peptides aiding nerve regeneration
US7176279B2 (en) * 2000-06-28 2007-02-13 Palatin Technologies, Inc. Cyclic peptide compositions and methods for treatment of sexual dysfunction
US6579968B1 (en) * 1999-06-29 2003-06-17 Palatin Technologies, Inc. Compositions and methods for treatment of sexual dysfunction
CA2419285C (en) * 2000-08-25 2011-08-02 Research Corporation Technologies, Inc. New uses for amino acid anticonvulsants
AU2002322466B2 (en) * 2001-07-11 2007-08-30 Palatin Technologies, Inc. Linear and cyclic melanocortin receptor-specific peptides
US6974187B2 (en) * 2004-01-28 2005-12-13 Tachi-S Co., Ltd. Vehicle seat structure
AU2005231034B2 (en) * 2004-04-08 2010-04-08 Telsar Pharma Inc. Compound WS727713
MXPA06011521A (es) 2004-04-08 2007-03-21 Astellas Pharma Inc Compuesto ws 727713.
US20130059914A1 (en) 2010-04-21 2013-03-07 Signature Therapeutics, Inc. Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
US11590209B2 (en) 2020-01-21 2023-02-28 Palatin Technologies, Inc. Use of bremelanotide in patients with controlled hypertension
AU2021382158C1 (en) * 2020-11-18 2026-05-07 Definium Therapeutics US, Inc. Mdma prodrugs to assist psychotherapy
KR20230174213A (ko) 2021-03-09 2023-12-27 엔사이스 바이오사이언시즈 인크. 나파모스타트의 변형된 방출 조성물 및 그의 사용 방법
CN117715632A (zh) 2021-03-09 2024-03-15 恩赛斯生物科学股份有限公司 包含酶可裂解的前药和萘莫司他的组合物及其使用方法
MX2024003466A (es) 2021-09-29 2024-06-04 Ensysce Biosciences Inc Profarmacos de metadona escindibles por enzimas y metodos de uso de los mismos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1302396A (fr) * 1961-03-10 1962-08-31 Ciba Geigy Procédés de préparation de nouveaux heptapeptides de formule l-alpha-[mercaptoalcoyl (inférieur)]-alpha-amino-acétyl-l-glutaminyl-l-histidyl-l-phényl alanyl-l-alpha-[amino-alcoyl (inférieur)]-alpha-amino-acétyl-l-tryptophyl glycine
NL278010A (enExample) * 1961-05-04 1900-01-01
NL6509727A (enExample) * 1965-07-28 1967-01-30
GB1230472A (enExample) * 1967-07-10 1971-05-05

Also Published As

Publication number Publication date
AU5197973A (en) 1974-08-08
CH585192A5 (enExample) 1977-02-28
HU168890B (enExample) 1976-08-28
US3853836A (en) 1974-12-10
CA1030953A (en) 1978-05-09
JPS4896586A (enExample) 1973-12-10
FR2181759B1 (enExample) 1976-09-03
AU471298B2 (en) 1976-04-15
GB1416271A (en) 1975-12-03
FR2181759A1 (enExample) 1973-12-07
NL7202278A (enExample) 1973-08-24
BE795788A (nl) 1973-08-22
ZA73839B (en) 1973-11-28

Similar Documents

Publication Publication Date Title
CH629475A5 (de) Verfahren zur herstellung von polypeptiden.
DE2315826C2 (de) Peptide und deren Derivate sowie diese Verbindungen enthaltende Arzneimittel mit psychopharmakologischer Wirkung
DE2649146A1 (de) Nonapeptide
DE2335826C2 (de) Peptide und deren Derivate sowie diese Verbindungen enthaltende Arzneimittel
CH636598A5 (de) Verfahren zur herstellung neuer psychopharmakologisch aktiver peptide.
DE2326033C2 (de) Peptide und deren Derivate sowie diese Verbindungen enthaltende Arzneimittel mit psychopharmakologischer Wirkung
EP0394194B1 (de) Geschützte Aminosäuren und Verfahren zu ihrer Herstellung
DE2544348A1 (de) L-leucin-13-motilin, verfahren zu dessen herstellung und dasselbe enthaltendes mittel
CH633523A5 (de) Verfahren zur herstellung von peptiden und peptidderivaten.
DE1248059B (de) Verfahren zur Herstellung bradykininwirksamer Undeca- und Dodecapeptide
CH420187A (de) Verfahren zur Herstellung eines bisher unbekannten Polypeptides
CH658661A5 (de) Peptidverbindungen.
DE2311099A1 (de) Psychopharmakologisch aktive peptide und peptidderivate
DE2649114A1 (de) Octapeptide
US3749704A (en) N-(omega-amino lower alkyl)-amides of 1,17-modified acth peptides
DE3411709A1 (de) Gonadoliberinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2305727A1 (de) Pentapeptide und ihre verwendung als psychopharmaka
CH437337A (de) Verfahren zur Herstellung von Peptiden
DE2010759C3 (de) Eckige Klammer auf beta- Ala hoch 1- eckige Klammer zu -ACTH (1- 18>NH tief 2, seine Salze mit Säuren und Komplexe mit Schwermetallen und Polyaminosäuren, sowe diese Verbindungen enthaltende Arzneimittel
CH499497A (de) Verfahren zur Herstellung neuer Polypeptide
AT390066B (de) Verfahren zur herstellung von neuen gonadoliberin-derivaten
AT249282B (de) Verfahren zur Herstellung neuer Heneikosapeptide
DE2108043A1 (de) Inhibitoren der Umwandlung von Angiotensin I in Angiotensin II
DE1518340C (de) Eledoisinwirksame Hexa und Hepta peptide und Verfahren zu deren Her stellung
CH436327A (de) Verfahren zur Herstellung eines neuen Polypeptids